Thursday, June 18, 2026

Cultural Invasion: How South Korea Plans to ‘Koreanize’ North Korean Soldiers with Pop Culture

Thae Yong Ho of the People Power Party expressed his strong support for the possibility of resuming loudspeaker broadcasts to North Korea ...

Beijing Meeting Could Signal New Diplomatic Gamble for North Korea

Kim Jong Un's upcoming visit to China marks a potential shift in North Korea's diplomatic strategy, responding to U.S.-South Korea ties.

“WHY BOTHER ASKING?” President Lee Mocked the Families of 46 Dead Sailors with a Sickening Smirk

President Lee Jae Myung faces criticism for not demanding an apology from North Korea regarding the Cheonan warship sinking.

Tag: FDA

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

How Angeliq and Other Treatments Are Transforming Menopausal Care in 2026

Daewon Pharmaceutical's symposium focused on menopausal hormone therapy, featuring discussions on Angeliq and recent clinical findings.

21 Companies Caught Misleading Consumers with False Health Claims on Haskap Berry Products

FDA warns against misleading ads for foods marketed as health supplements, leading to investigations of 21 companies for false claims.

U.S. FDA to Streamline IND Process: What It Means for Asian Biotech Competitiveness in 2027

The U.S. aims to streamline drug approval processes to compete with China and Australia in attracting clinical trials, enhancing biotech growth.

Seers Moves Closer to U.S. Launch of Wearable AI ECG Device After Completing Final FDA Filing

Wearable AI diagnostic firm Searis has completed the final document submission for FDA 510(k) approval of its mobiCARE™ ECG solution.

U.S., Japan and China Advance Stem Cell Commercialization While Korea Works to Close Gaps

The global stem cell therapy market is rapidly growing, but South Korea faces challenges in commercialization compared to the U.S. and Japan.

Wontech Expands Surgical Device Business With $2.2 Million HOLINWON Supply Deals in Uzbekistan and Indonesia

Wontech expands into surgical devices, securing $2.2M contracts in Asia for its advanced holmium laser technology.

HLB Group Maps Commercialization Push as It Awaits Key U.S. Cancer Drug Decisions

HLB Group seeks FDA approval for cancer drugs, aiming for global impact through innovation and collaboration in the biotech sector.

Artiva to Advance NK Cell Therapy Into Phase 3 for Rheumatoid Arthritis After Positive Mid-Stage Data

GC Cell's Artiva Biotherapeutics advances NK cell therapy AlloNK to Phase 3 trials for rheumatoid arthritis after promising Phase 2 results.

FDA Approval Allows AlphaTau to Broaden IMPACT Trial in Pancreatic Cancer

AlphaTau Medical expands its pancreatic cancer trial with FDA approval, adding 10 patients for a combination treatment approach.

L&K BioMed Showcases Innovative Products at the AANS Conference in Texas

L&K BioMed showcased its products at the AANS conference, receiving positive feedback and interest for its cervical products, aiming to expand in the U.S. market.

HLB Group Appoints Yang Eun-young President of Bio Business Development Division

HLB Group appoints Yang Eun-young as President of Bio Business Development, focusing on global partnerships and commercialization strategies.

Penetrium Bioscience Announces Finalization of New Clinical Strategy for Targeted Cancer Therapies

Penetrium Bioscience reveals new clinical strategy to combat drug resistance in cancer therapies at AACR 2026, launching Phase 2 trials.

CG Bio’s EasyMade TI: The First Custom Titanium Implant Approved by FDA 510(k) – What It Means for Patients

CG Bio's EasyMade TI titanium implant receives FDA 510(k) approval, marking a milestone for customized implants in the U.S. market.

Lunit supplies integrated breast cancer diagnostic solution to Lexington Clinic

Lunit supplies integrated breast cancer AI solutions to Lexington Clinic, enhancing diagnostics and expanding its presence in the Americas.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.